Table 4.
Laboratory parameters (ferritin levels, transferrin saturation, haemoglobin, and bicarbonate) (safety set)
| PA21 group | Sevelamer group | |
|---|---|---|
| Ferritin levels (pmol/L), median (quartiles: 25% and 75%) (n) | ||
| Week 0 | 95.50 (43.37, 255.03) (108) | 126.06 (44.94, 289.86) (105) |
| End of treatment | 202.23 (106.06, 312.33) (108) | 118.64 (55.73, 231.44) (105) |
| Change from Week 0 | 75.50 (11.68, 152.35) (108) | −5.62 (−57.97, 32.58) (105) |
| Serum transferrin saturation (%), mean ± SD (n) | ||
| Week 0 | 22.89 ± 9.50 (108) | 23.31 ± 10.20 (105) |
| End of treatment | 29.86 ± 13.51 (108) | 22.09 ± 9.96 (105) |
| Change from Week 0 | 6.97 ± 14.41 (108) | −1.22 ± 8.38 (105) |
| Haemoglobin (g/L), mean ± SD (n) | ||
| Week 0 | 105.50 ± 9.70 (108) | 106.40 ± 9.70 (104) |
| End of treatment | 114.10 ± 12.50 (108) | 103.10 ± 8.90 (105) |
| Change from Week 0 | 8.60 ± 11.50 (108) | −3.30 ± 9.40 (104) |
| Bicarbonate (mmol/L), mean ± SD (n) | ||
| Week 0 | 15.21 ± 2.17 (108) | 15.51 ± 2.07 (105) |
| End of treatment | 17.06 ± 2.24 (107) | 14.76 ± 2.18 (103) |
| Change from Week 0 | 1.89 ± 1.84 (107) | −0.71 ± 2.12 (103) |